Austin, TX -- (SBWIRE) -- 04/22/2013 -- Jackpotpennystocks.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news updates on the following stock:-
EXACT Sciences Corporation (NASDAQ:EXAS) shares climbed 4.47% to $9.23. The company on April 18 said its molecular screening test for colorectal cancer met a late-stage trial goal of detecting the disease in more patients than other commonly used tests, but shares plummeted as the results were not as robust as some were expecting.
Exact's test, which identifies abnormal DNA in cells shed in a patient's stool, detected 92 percent of colorectal cancers and 42 percent of pre-cancerous polyps in a large late-stage study.
Can EXAS Recover After The Recent fall? Find Out Here
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) shares increased 4.22% to $65.44. The company, on April 18, announced that on April 15, 2013, the compensation committee of BioMarin's board of directors approved the grant to 27 employees of stock options to purchase 32,500 shares of common stock in the aggregate and the grant to 25 of the 27 employees of 8,280 restricted stock units in the aggregate.
The stock options were granted pursuant to the BioMarin Pharmaceutical Inc. 2012 Inducement Plan, approved by the compensation committee of BioMarin's board of directors on May 8, 2012, and as inducements material to the new employees entering into employment with BioMarin in accordance with NASDAQ Listing Rule 5635(c)(4).
Can BMRN Continue To Move Higher? Find Out Here
UBS AG (USA) (NYSE:UBS) shares jumped 4.15% to $15.82. The company on April 16 named Oliver Bussmann as group CIO, adding an IT manager who is a big believer in the consumerization of IT.
Additionally, William Vereker, the former joint head of global investment banking at Nomura, on April 16 has joined UBS as head of corporate client solutions in Europe. The appointment is the latest move by Andrea Orcel, chief of UBS’s investment bank, to overhaul the division as the Swiss bank shifts its operations toward its wealth management unit.
Can UBS Extend Gain? Find Out Here
Jackpotpennystocks.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.
Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.
The assembled information disseminated by Jackpotpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Jackpotpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)